The FINANCIAL — Astellas Pharma Inc. on February 24 announced that it submitted a new drug application for a guanylate cyclase-C (GC-C) receptor agonist, linaclotide (generic name, ASP0456) for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results